StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report sent to investors on Monday. The firm issued a sell rating on the stock.
Ayala Pharmaceuticals Price Performance
Shares of Ayala Pharmaceuticals stock opened at $0.10 on Monday. The company’s fifty day simple moving average is $0.05 and its 200-day simple moving average is $0.30. The stock has a market capitalization of $4.31 million, a PE ratio of -0.01 and a beta of 1.51. Ayala Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $1.49.
About Ayala Pharmaceuticals
Recommended Stories
- Five stocks we like better than Ayala Pharmaceuticals
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- The Average 401k Balance by Age Explained
- How to Invest in the FAANG Stocks
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Roth IRA Calculator: Calculate Your Potential Returns
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.